(Q45861500)

17 December 2017

title

Evaluation of the porcine ameroid constrictor model of myocardial ischemia for therapeutic angiogenesis studies (English)

1 reference

17 December 2017

1 reference

Peter W Radke

1

1 reference

17 December 2017

Amanda Heinl-Green

2

1 reference

17 December 2017

Oliver M Frass

3

1 reference

17 December 2017

Mark J Post

4

1 reference

17 December 2017

Kaori Sato

5

1 reference

17 December 2017

Duncan M Geddes

6

1 reference

17 December 2017

Eric W F W Alton

7

1 reference

17 December 2017

publication date

1 January 2006

1 reference

17 December 2017

Endothelium: Journal of Endothelial Cell Research

published in

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

25-33

1 reference

17 December 2017

Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

The efficacy of a 'master switch gene' HIF-1alpha in a porcine model of chronic myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial 'delivery-efficacy' mismatch

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Coronary collateral development in swine after coronary artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Lack of correlation between angiographic grading of collateral and myocardial perfusion and function: implications for the assessment of angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

VEGF administration in chronic myocardial ischemia in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Coronary angiogenesis: detection in vivo with MR imaging sensitive to collateral neocirculation--preliminary study in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600660128

10.1080/10623320600660128

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017